288 results on '"Wal, Jean‐Michel"'
Search Results
2. Case studies on genetically modified organisms (GMOs): Potential risk scenarios and associated health indicators
3. Humoral and cellular immune response in Wistar Han RCC rats fed two genetically modified maize MON810 varieties for 90 days (EU 7th Framework Programme project GRACE)
4. Allergenicity of peanut component Ara h 2: Contribution of conformational versus linear hydroxyproline-containing epitopes
5. Modifying the infantʼs diet to prevent food allergy
6. Genetic basis and detection of unintended effects in genetically modified crop plants
7. Ninety-day oral toxicity studies on two genetically modified maize MON810 varieties in Wistar Han RCC rats (EU 7th Framework Programme project GRACE)
8. Immunochemical characterisation of structure and allergenicity of peanut 2S albumins using different formats of immunoassays
9. Comparison of the immune response induced in mice experimentally sensitized with genetically modified MON810 maize vs its conventional counterpart
10. Oral tolerance and functional Treg cells are induced in BALB/c mice after gavage with bovine β-lactoglobulin (BLG)
11. Sensitization to a purified cow’s milk (CM) allergen facilitates further oral sensitization to other CM proteins in mice
12. Allergenicity assessment of GMOs by the European safety authority
13. Delayed bacterial colonization of the gut alters the host immune response to oral sensitization against cowʼs milk proteins
14. Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation
15. Specificity of IgE antibodies from patients allergic to goatʼs milk and tolerant to cowʼs milk determined with plasmin-derived peptides of bovine and caprine β-caseins
16. Trypsin resistance of the major peanut allergen Ara h 6 and allergenicity of the digestion products are abolished after selective disruption of disulfide bonds
17. Boiling peanut Ara h 1 results in the formation of aggregates with reduced allergenicity
18. Allergenic and immunogenic potential of cowʼs milk β-lactoglobulin and caseins evidenced without adjuvant in germ-free mice
19. Assessment of genetically modified maize 1507 × NK603 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐008)
20. Update on optimized purification and characterization of natural milk allergens
21. IgE-Mediated food allergy diagnosis: Current status and new perspectives
22. Bovine milk allergenicity
23. Cowʼs milk proteins/allergens
24. Scientific Opinion on application EFSA‐GMO‐BE‐2013‐117 for authorisation of genetically modified maize MON 87427 × MON 89034 × NK603 and subcombinations independently of their origin, for food and feed uses, import and processing submitted under Regulation (EC) No 1829/2003 by Monsanto Company
25. Assessment of genetically modified sugar beet H7‐1 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐006)
26. Assessment of genetically modified soybean MON 87751 for food and feed uses under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2014‐121)
27. Assessment of genetically modified cotton GHB614 × LLCotton25 × MON 15985 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2011‐94)
28. Assessment of genetically modified maize MON 87403 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐BE‐2015‐125)
29. Effect of simulated gastro-duodenal digestion on the allergenic reactivity of beta-lactoglobulin
30. Efficient production and secretion of bovine β-lactoglobulin by Lactobacillus casei
31. Annual post‐market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2015 from Monsanto Europe S.A
32. Scientific Opinion on application EFSA‐GMO‐NL‐2013‐119 for authorisation of genetically modified glufosinate‐ammonium‐ and glyphosate‐tolerant oilseed rape MON 88302 × MS8 × RF3 and subcombinations independently of their origin, for food and feed uses, import and processing submitted in accordance with Regulation (EC) No 1829/2003 by Monsanto Company and Bayer CropScience
33. Scientific opinion on an application by Monsanto (EFSA‐GMO‐NL‐2013‐114) for the placing on the market of a herbicide‐tolerant genetically modified cotton MON 88701 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
34. Risk assessment of information on the subcombination Bt11 × MIR162, related to the application of Syngenta (EFSA‐GMO‐DE‐2009‐66) for authorisation of food and feed containing, consisting and produced from genetically modified maize Bt11 × MIR162 × MIR604 × GA21
35. Scientific opinion on an application by Dow AgroSciences LLC (EFSA‐GMO‐NL‐2012‐106) for the placing on the market of genetically modified herbicide‐tolerant soybean DAS‐44406‐6 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
36. Scientific Opinion on an application by Dow AgroSciences LLC (EFSA‐GMO‐NL‐2011‐91) for the placing on the market of genetically modified herbicide‐tolerant soybean DAS‐68416‐4 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
37. Scientific opinion on application EFSA‐GMO‐BE‐2013‐118 for authorisation of genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 59122 and subcombinations independently of their origin, for food and feed uses, import and processing submitted under Regulation (EC) No 1829/2003 by Monsanto Company
38. Outcome of the European Member States and Public consultations on the draft guidance for the risk assessment of the presence at low level of genetically modified plant material in imported food and feed under Regulation (EC)
39. Scientific opinion on an application for renewal of authorisation for continued marketing of maize 59122 and derived food and feed submitted under articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences LLC
40. Guidance for the risk assessment of the presence at low level of genetically modified plant material in imported food and feed under Regulation (EC) No 1829/2003
41. Assessment of genetically modified maize 1507 × 59122 × MON810 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2011‐92)
42. Scientific opinion on an application for renewal of authorisation for continued marketing of maize 1507 and derived food and feed submitted under Articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences LLC
43. Risk assessment of new sequencing information on GM maize event DAS‐59122‐7
44. Scientific Opinion on an application by Syngenta (EFSA-GMO-DE-2011-99) for the placing on the market of maize Bt11 × 59122 × MIR604 × 1507 × GA21 and twenty subcombinations, which have not been authorised previously independently of their origin, for food and feed uses, import and processing under Regulation (EC) No 1829/2003
45. Scientific Opinion on an application by Pioneer (EFSA-GMO-NL-2007-47) for the placing on the market of the herbicide-tolerant, high-oleic acid, genetically modified soybean 305423 3 40-3-2 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
46. Scientific Opinion on an application by Bayer CropScience and Monsanto (EFSA-GMO-NL-2009-75) for placing on the market of genetically modified glufosinate-ammonium- and glyphosate-tolerant oilseed rape MS8 3 RF3 3 GT73 and subcombinations, which have not been authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73) independently of their origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food, under Regulation (EC) No 1829/2003
47. Scientific Opinion on an application by Pioneer (EFSA-GMO-NL-2007-47) for the placing on the market of the herbicide-tolerant, high-oleic acid, genetically modified soybean 305423 × 40-3-2 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
48. Scientific Opinion on an application by Bayer CropScience and Monsanto (EFSA-GMO-NL-2009-75) for placing on the market of genetically modified glufosinate-ammonium- and glyphosate-tolerant oilseed rape MS8 × RF3 × GT73 and subcombinations, which have not been authorised previously (i.e. MS8 × GT73 and RF3 × GT73) independently of their origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food, under Regulation (EC) No 1829/2003
49. Annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2014 from Monsanto Europe S.A
50. Part C notification (reference C/NL/13/02) from Suntory Holdings Limited for the import, distribution and retailing of carnation FLO-40685-2 cut flowers with modified petal colour for ornamental use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.